Jennifer Kamocsay serves as Executive at Akoya Biosciences, Inc., where they oversee executive responsibilities. Since joining the company, Jennifer Kamocsay has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 8, 2025 involved transacting 16,772 shares valued at $0.
Jennifer Kamocsay currently holds 162,500 shares of Akoya Biosciences, Inc. (AKYA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Kamocsay has been a net neutral trader of AKYA stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Kamocsay's most recent insider trade was on Jul 8, 2025, when they sold 16,772 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 1, 2024 | AKYA | $19.8K | Payment | 3,283 | $6.03 | Discretionary |
| Feb 22, 2024 | AKYA | $0 | Award | 35,000 | $N/A | Discretionary |
| Nov 6, 2023 | AKYA | $0 | Award | 30,000 | $N/A | Discretionary |
| Mar 20, 2023 | AKYA | $0 | Award | 37,500 | $N/A | Discretionary |